Management of the interaction between tacrolimus and nirmatrelvir/ritonavir in the treatment of COVID-19 in solid organ transplantation

被引：0
作者：
Leclerc, Vincent [1 ,3 ]
Sanctuaire, Alexandre [1 ]
Chateauvert, Nathalie [1 ,2 ]
机构：
[1] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Dept Pharm, Quebec City, PQ, Canada
[2] Pneumol Quebec Univ Laval IUCPQ UL, Inst Univ cardiol, Ctr Rech, Quebec City, PQ, Canada
[3] Univ Laval, Inst Univ Cardiol & Pneumol Quebec, 2725 Chemin Se Foy, Quebec City, PQ G1V 4G5, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2023年 / 76卷 / 03期
关键词：
D O I：
10.4212/cjhp.3352
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：254 / 256
页数：3
相关论文
共 50 条
  • [41] An overview of COVID-19 in solid organ transplantation
    Bartelt, Luther
    van Duin, David
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (06) : 779 - 784
  • [42] Impact of COVID-19 on Solid Organ Transplantation
    Sampson, E.
    Hall, S.
    Robichaux, K.
    Kumar, A.
    Kemmer, N.
    Buggs, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 353 - 354
  • [43] Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19
    Boland, Lidvine
    Devresse, Arnaud
    Monchaud, Caroline
    Briol, Sebastien
    Belaiche, Stephanie
    Giguet, Baptiste
    Couzi, Lionel
    Thaunat, Olivier
    Esposito, Laure
    Meszaros, Magdalena
    Roussoulieres, Ana
    Haufroid, Vincent
    Le Meur, Yannick
    Lemaitre, Florian
    TRANSPLANT INTERNATIONAL, 2024, 37
  • [44] Nirmatrelvir/ritonavir well tolerated for COVID-19 in patients with CKD
    Reactions Weekly, 2023, 1969 (1) : 12 - 12
  • [45] Management and Outcome of COVID-19 Infection Using Nirmatrelvir/Ritonavir in Kidney Transplant Patients
    Giguere, Pierre
    Deschenes, Marie-Josee
    Van Loon, MacKenzie
    Hoar, Stephanie
    Fairhead, Todd
    Pazhekattu, Rinu
    Knoll, Greg
    Karpinski, Jolanta
    Parikh, Namrata
    McDougall, Jessica
    McGuinty, Michaeline
    Hiremath, Swapnil
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (07): : 913 - 919
  • [46] Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark?
    Hung, Yuan-Pin
    Lee, Jen-Chieh
    Chiu, Chun-Wei
    Lee, Ching-Chi
    Tsai, Pei-Jane
    Hsu, I-Lin
    Ko, Wen-Chien
    ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [47] Oral Nirmatrelvir-Ritonavir as Postexposure Prophylaxis for Covid-19
    Hammond, Jennifer
    Yunis, Carla
    Fountaine, Robert J.
    Luscan, Gerald
    Burr, Aimee M.
    Zhang, Wuyan
    Wisemandle, Wayne
    Soares, Holly
    Baniecki, Mary Lynn
    Hendrick, Victoria M.
    Kalfov, Veselin
    Pypstra, Rienk
    Rusnak, James M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (03) : 224 - 234
  • [48] Rebound of COVID-19 With Nirmatrelvir-Ritonavir Antiviral Therapy
    Cohen, Myron S.
    Brown, Elizabeth R.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1672 - 1673
  • [49] Factors influencing Nirmatrelvir/Ritonavir concentration in patients with COVID-19
    Xu, Ping
    Zhang, Lijun
    Wu, Qingguo
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [50] Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
    Hashemian, Seyed Mohammad Reza
    Sheida, Amirhossein
    Taghizadieh, Mohammad
    Memar, Mohammad Yousef
    Hamblin, Michael R.
    Baghi, Hossein Bannazadeh
    Nahand, Javid Sadri
    Asemi, Zatollah
    Mirzaei, Hamed
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
12345